Skip to main content

Vitamin D insufficiency: implications for the immune system

Abstract

Chronic kidney disease (CKD) is characterized by a loss of kidney function and dysregulation of vitamin D metabolism. Well known are the defects in final activation of vitamin D to 1,25-dihydroxyvitamin D3 [1,25(OH)2D3], resulting in renal osteodystrophy. However, in recent years, 1,25(OH)2D3 has been identified as having effects far beyond calcium and bone metabolism. In this review, specific attention is given to the effects of 1,25(OH)2D3 on the immune system and the implications of vitamin D deficiency, a feature of many patients with CKD, on immune function.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2

References

  1. 1.

    National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201

    Google Scholar 

  2. 2.

    Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R (2005) Estimates of optimal vitamin D status. Osteoporos Int 16:713–716

    Article  PubMed  CAS  Google Scholar 

  3. 3.

    Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 135:317–322

    PubMed  CAS  Google Scholar 

  4. 4.

    Janssen HC, Samson MM, Verhaar HJ (2002) Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 75:611–615

    PubMed  CAS  Google Scholar 

  5. 5.

    Bouillon R, Bischoff-Ferrari H, Willett W (2008) Vitamin D and health: perspectives from mice and man. J Bone Miner Res 23:974–979

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Holick MF (1997) Photobiology of vitamin D. In: Feldman D, Glorieux FH, Pike J (eds) Vitamin D. Academic Press, San Diego, pp 33–39

    Google Scholar 

  7. 7.

    Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289:F8–F28

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Marcinkowska E (2001) A run for a membrane vitamin D receptor. Biol Signals Recept 10:341–349

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Bikle D (2009) Nonclassic actions of vitamin D. J Clin Endocrinol Metab 94:26–34

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Townsend K, Evans KN, Campbell MJ, Colston KW, Adams JS, Hewison M (2005) Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol 97:103–109

    Article  PubMed  CAS  Google Scholar 

  11. 11.

    Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC (1983) 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science 221:1181–1183

    Article  PubMed  CAS  Google Scholar 

  12. 12.

    Veldman CM, Cantorna MT, DeLuca HF (2000) Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374:334–338

    Article  PubMed  CAS  Google Scholar 

  13. 13.

    Takahashi K, Nakayama Y, Horiuchi H, Ohta T, Komoriya K, Ohmori H, Kamimura T (2002) Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha, 25-dihydroxyvitamin D3. Immunopharmacol Immunotoxicol 24:335–347

    Article  PubMed  CAS  Google Scholar 

  14. 14.

    Monkawa T, Yoshida T, Hayashi M, Saruta T (2000) Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int 58:559–568

    Article  PubMed  CAS  Google Scholar 

  15. 15.

    Overbergh L, Decallonne B, Valckx D, Verstuyf A, Depovere J, Laureys J, Rutgeerts O, Saint-Arnaud R, Bouillon R, Mathieu C (2000) Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 120:139–146

    Article  PubMed  CAS  Google Scholar 

  16. 16.

    Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R (2003) Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 170:5382–5390

    PubMed  CAS  Google Scholar 

  17. 17.

    Chen S, Sims GP, Chen XX, Gu YY, Chen S, Lipsky PE (2007) Modulatory effects of 1, 25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 179:1634–1647

    PubMed  CAS  Google Scholar 

  18. 18.

    Sigmundsdottir H, Pan J, Debes GF, Alt C, Habtezion A, Soler D, Butcher EC (2007) DCs metabolize sunlight-induced vitamin D3 to ‘program’ T cell attraction to the epidermal chemokine CCL27. Nat Immunol 8:285–293

    Article  PubMed  CAS  Google Scholar 

  19. 19.

    van Etten E, Stoffels K, Gysemans C, Mathieu C, Overbergh L (2008) Regulation of vitamin D homeostasis: implications for the immune system. Nutr Rev 66:S125–S134

    Article  PubMed  Google Scholar 

  20. 20.

    Kreutz M, Andreesen R, Krause SW, Szabo A, Ritz E, Reichel H (1993) 1, 25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 82:1300–1307

    PubMed  CAS  Google Scholar 

  21. 21.

    Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zugel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL (2006) Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311:1770–1773

    Article  PubMed  CAS  Google Scholar 

  22. 22.

    Chan TY (2000) Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int 66:476–478

    Article  PubMed  CAS  Google Scholar 

  23. 23.

    Kankova M, Luini W, Pedrazzoni M, Riganti F, Sironi M, Bottazzi B, Mantovani A, Vecchi A (1991) Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73:466–471

    PubMed  CAS  Google Scholar 

  24. 24.

    Giulietti A, Gysemans C, Stoffels K, van Etten E, Decallonne B, Overbergh L, Bouillon R, Mathieu C (2004) Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice. Diabetologia 47:451–462

    Article  PubMed  CAS  Google Scholar 

  25. 25.

    Griffin MD, Xing N, Kumar R (2003) Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23:117–145

    Article  PubMed  CAS  Google Scholar 

  26. 26.

    Xu H, Soruri A, Gieseler RK, Peters JH (1993) 1, 25-Dihydroxyvitamin D3 exerts opposing effects to IL-4 on MHC class-II antigen expression, accessory activity, and phagocytosis of human monocytes. Scand J Immunol 38:535–540

    Article  PubMed  CAS  Google Scholar 

  27. 27.

    Rook GA, Steele J, Fraher L, Barker S, Karmali R, O’Riordan J, Stanford J (1986) Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 57:159–163

    PubMed  CAS  Google Scholar 

  28. 28.

    Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, Tavera-Mendoza L, Lin R, Hanrahan JW, Mader S, White JH (2004) Cutting edge: 1, 25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173:2909–2912

    PubMed  CAS  Google Scholar 

  29. 29.

    Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G (2007) Induction of cathelicidin in normal and CF bronchial epithelial cells by 1, 25-dihydroxyvitamin D(3). J Cyst Fibros 6:403–410

    Article  PubMed  CAS  Google Scholar 

  30. 30.

    Gombart AF, O’Kelly J, Saito T, Koeffler HP (2007) Regulation of the CAMP gene by 1, 25(OH)2D3 in various tissues. J Steroid Biochem Mol Biol 103:552–557

    Article  PubMed  CAS  Google Scholar 

  31. 31.

    Krutzik SR, Hewison M, Liu PT, Robles JA, Stenger S, Adams JS, Modlin RL (2008) IL-15 links TLR2/1-induced macrophage differentiation to the vitamin D-dependent antimicrobial pathway. J Immunol 181:7115–7120

    PubMed  CAS  Google Scholar 

  32. 32.

    Liu PT, Schenk M, Walker VP, Dempsey PW, Kanchanapoomi M, Wheelwright M, Vazirnia A, Zhang X, Steinmeyer A, Zugel U, Hollis BW, Cheng G, Modlin RL (2009) Convergence of IL-1beta and VDR activation pathways in human TLR2/1-induced antimicrobial responses. PLoS One 4:e5810

    Article  PubMed  CAS  Google Scholar 

  33. 33.

    Sly LM, Lopez M, Nauseef WM, Reiner NE (2001) 1alpha, 25-Dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 276:35482–35493

    Article  PubMed  CAS  Google Scholar 

  34. 34.

    Rockett KA, Brookes R, Udalova I, Vidal V, Hill AV, Kwiatkowski D (1998) 1, 25-Dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 66:5314–5321

    PubMed  CAS  Google Scholar 

  35. 35.

    Chang JM, Kuo MC, Kuo HT, Hwang SJ, Tsai JC, Chen HC, Lai YH (2004) 1-alpha, 25-Dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J Lab Clin Med 143:14–22

    Article  PubMed  CAS  Google Scholar 

  36. 36.

    Sadeghi K, Wessner B, Laggner U, Ploder M, Tamandl D, Friedl J, Zugel U, Steinmeyer A, Pollak A, Roth E, Boltz-Nitulescu G, Spittler A (2006) Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 36:361–370

    Article  PubMed  CAS  Google Scholar 

  37. 37.

    Cantorna MT, Mahon BD (2004) Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence. Exp Biol Med (Maywood) 229:1136–1142

    CAS  Google Scholar 

  38. 38.

    van Etten E, Mathieu C (2005) Immunoregulation by 1, 25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97:93–101

    Article  PubMed  CAS  Google Scholar 

  39. 39.

    Baeke F, van Etten E, Overbergh L, Mathieu C (2007) Vitamin D3 and the immune system: maintaining the balance in health and disease. Nutr Res Rev 20:106–118

    Article  PubMed  CAS  Google Scholar 

  40. 40.

    Penna G, Adorini L (2000) 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 164:2405–2411

    PubMed  CAS  Google Scholar 

  41. 41.

    van Halteren AG, van Etten E, de Jong EC, Bouillon R, Roep BO, Mathieu C (2002) Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1, 25 dihydroxyvitamin D(3). Diabetes 51:2119–2125

    Article  PubMed  Google Scholar 

  42. 42.

    Gauzzi MC, Purificato C, Donato K, Jin Y, Wang L, Daniel KC, Maghazachi AA, Belardelli F, Adorini L, Gessani S (2005) Suppressive effect of 1alpha, 25-dihydroxyvitamin D3 on type I IFN-mediated monocyte differentiation into dendritic cells: impairment of functional activities and chemotaxis. J Immunol 174:270–276

    PubMed  CAS  Google Scholar 

  43. 43.

    Pedersen AW, Holmstrom K, Jensen SS, Fuchs D, Rasmussen S, Kvistborg P, Claesson MH, Zocca MB (2009) Phenotypic and functional markers for 1alpha, 25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol 157:48–59

    Article  PubMed  CAS  Google Scholar 

  44. 44.

    Penna G, Amuchastegui S, Giarratana N, Daniel KC, Vulcano M, Sozzani S, Adorini L (2007) 1, 25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells. J Immunol 178:145–153

    PubMed  CAS  Google Scholar 

  45. 45.

    Zhu J, Paul WE (2008) CD4 T cells: fates, functions, and faults. Blood 112:1557–1569

    Article  PubMed  CAS  Google Scholar 

  46. 46.

    Mosser DM, Zhang X (2008) Interleukin-10: new perspectives on an old cytokine. Immunol Rev 226:205–218

    Article  PubMed  CAS  Google Scholar 

  47. 47.

    D’Ambrosio D (2006) Regulatory T cells: how do they find their space in the immunological arena? Semin Cancer Biol 16:91–97

    Article  PubMed  CAS  Google Scholar 

  48. 48.

    Ferreira GB, van Etten E, Lage K, Hansen DA, Moreau Y, Workman CT, Waer M, Verstuyf A, Waelkens E, Overbergh L, Mathieu C (2009) Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 9:3752–3764

    Article  PubMed  CAS  Google Scholar 

  49. 49.

    Almerighi C, Sinistro A, Cavazza A, Ciaprini C, Rocchi G, Bergamini A (2009) 1Alpha, 25-dihydroxyvitamin D3 inhibits CD40L-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 45:190–197

    Article  PubMed  CAS  Google Scholar 

  50. 50.

    D’Ambrosio D, Cippitelli M, Cocciolo MG, Mazzeo D, Di Lucia P, Lang R, Sinigaglia F, Panina-Bordignon P (1998) Inhibition of IL-12 production by 1, 25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest 101:252–262

    Article  PubMed  Google Scholar 

  51. 51.

    Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C (2007) Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res Clin Pract 77:47–57

    Article  PubMed  CAS  Google Scholar 

  52. 52.

    van Halteren AG, Tysma OM, van Etten E, Mathieu C, Roep BO (2004) 1alpha, 25-dihydroxyvitamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis. J Autoimmun 23:233–239

    Article  PubMed  CAS  Google Scholar 

  53. 53.

    Tang J, Zhou R, Luger D, Zhu W, Silver PB, Grajewski RS, Su SB, Chan CC, Adorini L, Caspi RR (2009) Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response. J Immunol 182:4624–4632

    Article  PubMed  CAS  Google Scholar 

  54. 54.

    Penna G, Roncari A, Amuchastegui S, Daniel KC, Berti E, Colonna M, Adorini L (2005) Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1, 25-dihydroxyvitamin D3. Blood 106:3490–3497

    Article  PubMed  CAS  Google Scholar 

  55. 55.

    Ghoreishi M, Bach P, Obst J, Komba M, Fleet JC, Dutz JP (2009) Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol. J Immunol 182:6071–6078

    Article  PubMed  CAS  Google Scholar 

  56. 56.

    Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L (2002) A 1alpha, 25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes 51:1367–1374

    Article  PubMed  CAS  Google Scholar 

  57. 57.

    Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324:23–33

    Article  PubMed  CAS  Google Scholar 

  58. 58.

    Gorman S, Kuritzky LA, Judge MA, Dixon KM, McGlade JP, Mason RS, Finlay-Jones JJ, Hart PH (2007) Topically applied 1, 25-dihydroxyvitamin D3 enhances the suppressive activity of CD4+CD25+ cells in the draining lymph nodes. J Immunol 179:6273–6283

    PubMed  CAS  Google Scholar 

  59. 59.

    Szeles L, Keresztes G, Torocsik D, Balajthy Z, Krenacs L, Poliska S, Steinmeyer A, Zuegel U, Pruenster M, Rot A, Nagy L (2009) 1, 25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J Immunol 182:2074–2083

    Article  PubMed  CAS  Google Scholar 

  60. 60.

    Bhalla AK, Amento EP, Serog B, Glimcher LH (1984) 1, 25-Dihydroxyvitamin D3 inhibits antigen-induced T cell activation. J Immunol 133:1748–1754

    PubMed  CAS  Google Scholar 

  61. 61.

    Rigby WF, Stacy T, Fanger MW (1984) Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 74:1451–1455

    Article  PubMed  CAS  Google Scholar 

  62. 62.

    Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A (2001) 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167:4974–4980

    PubMed  CAS  Google Scholar 

  63. 63.

    Borgogni E, Sarchielli E, Sottili M, Santarlasci V, Cosmi L, Gelmini S, Lombardi A, Cantini G, Perigli G, Luconi M, Vannelli GB, Annunziato F, Adorini L, Serio M, Crescioli C (2008) Elocalcitol inhibits inflammatory responses in human thyroid cells and T cells. Endocrinology 149:3626–3634

    Article  PubMed  CAS  Google Scholar 

  64. 64.

    Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O’Garra A (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195:603–616

    Article  PubMed  CAS  Google Scholar 

  65. 65.

    Urry Z, Xystrakis E, Richards DF, McDonald J, Sattar Z, Cousins DJ, Corrigan CJ, Hickman E, Brown Z, Hawrylowicz CM (2009) Ligation of TLR9 induced on human IL-10-secreting Tregs by 1alpha, 25-dihydroxyvitamin D3 abrogates regulatory function. J Clin Invest 119:387–398

    PubMed  CAS  Google Scholar 

  66. 66.

    Shirakawa AK, Nagakubo D, Hieshima K, Nakayama T, Jin Z, Yoshie O (2008) 1, 25-dihydroxyvitamin D3 induces CCR10 expression in terminally differentiating human B cells. J Immunol 180:2786–2795

    PubMed  CAS  Google Scholar 

  67. 67.

    Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38

    Article  PubMed  CAS  Google Scholar 

  68. 68.

    Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H (1999) Serum levels of 1, 25-dihydroxyvitamin D, 24, 25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55:1019–1027

    Article  PubMed  CAS  Google Scholar 

  69. 69.

    Cozzolino M, Gallieni M, Brancaccio D, Arcidiacono T, Bianchi G, Vezzoli G (2006) Vitamin D retains an important role in the pathogenesis and management of secondary hyperparathyroidism in chronic renal failure. J Nephrol 19:566–577

    PubMed  CAS  Google Scholar 

  70. 70.

    LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026–1033

    Article  PubMed  CAS  Google Scholar 

  71. 71.

    Shah N, Bernardini J, Piraino B (2005) Prevalence and correction of 25(OH) vitamin D deficiency in peritoneal dialysis patients. Perit Dial Int 25:362–366

    PubMed  CAS  Google Scholar 

  72. 72.

    Gonzalez EA, Sachdeva A, Oliver DA, Martin KJ (2004) Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 24:503–510

    Article  PubMed  CAS  Google Scholar 

  73. 73.

    Del Valle E, Negri AL, Aguirre C, Fradinger E, Zanchetta JR (2007) Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int 11:315–321

    Article  PubMed  Google Scholar 

  74. 74.

    Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK (2008) Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23:1831–1836

    Article  PubMed  Google Scholar 

  75. 75.

    Belostotsky V, Mughal MZ, Berry JL, Webb NJ (2008) Vitamin D deficiency in children with renal disease. Arch Dis Child 93:959–962

    Article  PubMed  CAS  Google Scholar 

  76. 76.

    Seeherunvong W, Abitbol CL, Chandar J, Zilleruelo G, Freundlich M (2009) Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 154:906–911

    Article  PubMed  CAS  Google Scholar 

  77. 77.

    Ali FN, Arguelles LM, Langman CB, Price HE (2009) Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic. Pediatrics 123:791–796

    Article  PubMed  Google Scholar 

  78. 78.

    Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R (2007) Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72:1004–1013

    Article  PubMed  CAS  Google Scholar 

  79. 79.

    Inaguma D, Nagaya H, Hara K, Tatematsu M, Shinjo H, Suzuki S, Mishima T, Kurata K (2008) Relationship between serum 1, 25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease. Clin Exp Nephrol 12:126–131

    Article  PubMed  CAS  Google Scholar 

  80. 80.

    Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115–1125

    Article  PubMed  CAS  Google Scholar 

  81. 81.

    Tentori F, Hunt WC, Stidley CA, Rohrscheib MR, Bedrick EJ, Meyer KB, Johnson HK, Zager PG (2006) Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 70:1858–1865

    Article  PubMed  CAS  Google Scholar 

  82. 82.

    Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R (2008) Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 19:1379–1388

    Article  PubMed  CAS  Google Scholar 

  83. 83.

    Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF (2007) Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147:840–853

    PubMed  Google Scholar 

  84. 84.

    Stenvinkel P (2006) Inflammation in end-stage renal disease: the hidden enemy. Nephrology (Carlton) 11:36–41

    Article  Google Scholar 

  85. 85.

    Levin A, Li YC (2005) Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease? Kidney Int 68:1973–1981

    Article  PubMed  CAS  Google Scholar 

  86. 86.

    Zehnder D, Quinkler M, Eardley KS, Bland R, Lepenies J, Hughes SV, Raymond NT, Howie AJ, Cockwell P, Stewart PM, Hewison M (2008) Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int 74:1343–1353

    Article  PubMed  CAS  Google Scholar 

  87. 87.

    Tan X, Wen X, Liu Y (2008) Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling. J Am Soc Nephrol 19:1741–1752

    Article  PubMed  CAS  Google Scholar 

  88. 88.

    Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R (2009) Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 48:418–424

    Article  PubMed  CAS  Google Scholar 

  89. 89.

    National Kidney Foundation (2005) K/DOQI clinical practice guidelines for bone metabolism and disease in children with chronic kidney disease. Am J Kidney Dis 46:S1–S121

    Google Scholar 

Download references

Acknowledgements

This work was supported by grants of the Flemish Research Foundation [Fonds Voor Wetenschappelijk Onderzoek (FWO) Vlaanderen G.0552.06 and G.0649.08, a postdoctoral fellowship for Conny Gysemans and Hannelie Korf and a clinical fellowship for Chantal Mathieu], of the Belgium Program on Interuniversity Poles of Attraction initiated by the Belgian State (IAP P5/17 and P6/40), of the Katholieke Universiteit Leuven (GOA 2004/10 and GOA 2009/10), of the 6th Framework Program of the European Union with acronym SAVEBETA as well as of the 7th Framework Program of the European Union with acronym NAIMIT and of the JDRF Center for Prevention of Beta Cell Therapy in Diabetes [grant number 4-2005-1327].

Author information

Affiliations

Authors

Corresponding author

Correspondence to Chantal Mathieu.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Baeke, F., Gysemans, C., Korf, H. et al. Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol 25, 1597–1606 (2010). https://doi.org/10.1007/s00467-010-1452-y

Download citation

Keywords

  • Vitamin D
  • Immune modulation
  • Chronic kidney disease